Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
92 hedge funds and large institutions have $298M invested in Lumos Pharma, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 27 reducing their positions, and 8 closing their positions.
74% more call options, than puts
Call options by funds: $33.7M | Put options by funds: $19.4M
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
30% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 27
5% more funds holding
Funds holding: 88 → 92 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $353M → $298M (-$55.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
+$7.94M |
| 2 |
HT
HAP Trading
New York
|
+$5.09M |
| 3 |
DFO
Duquesne Family Office
New York
|
+$4.46M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.54M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$2.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$3.71M |
| 2 |
ST
Spot Trading
Chicago,
Illinois
|
-$3.58M |
| 3 |
JG
Jefferies Group
New York
|
-$1.82M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$1.33M |
| 5 |
BCM
Bluefin Capital Management
New York
|
-$1.32M |
LUMO Hedge Fund Activity: Q3 2014 in Review
92 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q3 2014, worth a combined $298M — down 16% from $353M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new LUMO positions and 8 closed out — a net gain of 5 holders — while 35 added to existing stakes and 27 trimmed.
The largest buyer was PointState Capital, adding an estimated $7.94M. The largest seller was Franklin Resources, cutting an estimated $3.71M.
- 92 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q3 2014, up from 88 in Q2 2014.
- Funds reported $298M of Lumos Pharma, Inc. Common Stock stock for Q3 2014, down 16% quarter-over-quarter.
- 13 funds opened new Lumos Pharma, Inc. Common Stock positions in Q3 2014 and 8 closed out, a net change of +5 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q3 2014 was PointState Capital, an estimated $7.94M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q3 2014 was Franklin Resources, an estimated $3.71M sold.
Based on aggregated 13F filings for Q3 2014.